Patiromer is a divinylbenzene-based polymer drug classified as a potassium binder that is indicated for the management of hyperkalemia in patients with chronic kidney disease. This medication functions… Read more
Patiromer is a divinylbenzene-based polymer drug classified as a potassium binder that is indicated for the management of hyperkalemia in patients with chronic kidney disease. This medication functions by selectively binding dietary potassium in the gastrointestinal tract, facilitating its excretion to help lower serum potassium levels. This category provides access to high-quality reference standards, including associated impurities and related compounds necessary for comprehensive analytical testing. Pharmaceutical laboratories rely on these reference materials for impurity profiling, method development, and rigorous quality control protocols to ensure the consistency and safety of the polymer formulation. By utilizing precise, stable isotope labelled compounds and identified degradation products, researchers can accurately validate their analytical methods throughout the product lifecycle. These materials are essential tools for maintaining strict compliance with pharmacopeial standards and supporting the reliable characterization of this therapeutic agent.